- Kelly Goldsmith Named Co-Leader of Discovery & Developmental Therapeutics Program at Emory University Winship Cancer Institute
September 18, 2021
September 18, 2021
ATLANTA, Georgia, Sept. 18 (TNSPer) -- Emory University's Winship Cancer Institute issued the following news release:
Kelly C. Goldsmith, MD, a physician-scientist specializing in pediatric oncology, has been named co-leader of the Discovery and Developmental Therapeutics (DDT) Program, one of four research programs within Winship Cancer Institute of Emory University.
Effective September 20, 2021, Goldsmith will serve in this role alongside Haian Fu, PhD, who has led th . . .
Kelly C. Goldsmith, MD, a physician-scientist specializing in pediatric oncology, has been named co-leader of the Discovery and Developmental Therapeutics (DDT) Program, one of four research programs within Winship Cancer Institute of Emory University.
Effective September 20, 2021, Goldsmith will serve in this role alongside Haian Fu, PhD, who has led th . . .